Wednesday, February 20, 2019

Hot Medical Stocks For 2019

tags:MIK,CRT,JHX,

This has certainly been a year for marijuana "firsts." Since the year began, Cronos Group became the first pot stock to uplist from the over-the-counter exchanges to a more reputable exchange, the Nasdaq, and Vermont made history by becoming the first state to OK adult-use marijuana entirely through the legislative process.

Looking ahead to June, Canada aims to become the first developed country in the world to legalize recreational marijuana, and cannabinoid-based drug developer GW Pharmaceuticals may get Food and Drug Administration (FDA) approval for Epidiolex as a treatment for two rare types of childhood-onset epilepsy. If approval is granted, it would mark the first time a cannabis-derived drug has gained the FDA's favor.

Image source: Getty Images.

Residents in these states will be voting on a marijuana initiative this year

Of course, history is nowhere near done being made this year. There are no shortage of states with initiatives aiming to legalize medical or recreational cannabis in the 2018 elections. Here are two states where residents will absolutely be voting on a cannabis initiative at some point this year.

Hot Medical Stocks For 2019: The Michaels Companies, Inc.(MIK)

Advisors' Opinion:
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Michaels Companies (MIK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund]

    Shares of Michaels Companies (NASDAQ:MIK) fell as much as 19.1% lower on Thursday morning, following the release of solid first-quarter earnings with a side of modest next-period guidance. At 12:50 p.m. EDT, the stock had recovered only slightly to reach a 17.6% price drop.

  • [By Anders Bylund]

    Arts and crafts retailer The Michaels Companies (NASDAQ:MIK) reported second-quarter results early Thursday morning. The company beat its bottom-line guidance and raised full-year earnings targets, despite soft comparable store sales and a revenue-clogging store remodeling program.

Hot Medical Stocks For 2019: Cross Timbers Royalty Trust(CRT)

Advisors' Opinion:
  • [By Ethan Ryder]

    Cross Timbers Royalty Trust (NYSE:CRT) announced a dividend on Tuesday, August 21st, NASDAQ reports. Stockholders of record on Friday, August 31st will be paid a dividend of 0.108 per share by the oil and gas company on Monday, September 17th. The ex-dividend date of this dividend is Thursday, August 30th.

  • [By Ethan Ryder]

    News stories about Cross Timbers Royalty Trust (NYSE:CRT) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cross Timbers Royalty Trust earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned headlines about the oil and gas company an impact score of 47.0297657024049 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Hot Medical Stocks For 2019: James Hardie Industries plc.(JHX)

Advisors' Opinion:
  • [By Shane Hupp]

    Media headlines about James Hardie Industries (NYSE:JHX) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. James Hardie Industries earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned press coverage about the construction company an impact score of 45.4803891697197 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

No comments:

Post a Comment